Mary Sylvia has nearly 30 years experience in microbiology and patent law. Trained initially as a molecular virologist, she focuses primarily on biotech plant and pharmaceutical patent law and the development of intellectual property strategy in both procurement and litigation settings. Having served as in-house counsel, as well as working in molecular biology and genetics labs prior to law school, she brings a unique perspective to how to approach IP portfolio development strategies and the key considerations for plant developers.
Press CTRL+C to copy embed code to clipboard
